Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by robertshawon Sep 11, 2020 10:29am
103 Views
Post# 31542085

RE:RE:RE:RE:RE:I am hopefull That we get updates on

RE:RE:RE:RE:RE:I am hopefull That we get updates on
jojomarch wrote: Excellent post Thor , I share your opinion probably with a few other posters . This mentality of not wanting to share control is hurting TLT ,its shareholders and more importantly the the patients . When you really care about the future of your company your salary is not a priority . TLT has been around for more than 20 years if I am not mistaking , without any profits . I can safely assume that no posters here could run a business that way for more than 20 years without closing shop at one point . Happy Friday P.S. Still would like to know Sherri's opinion of how things have been managed in the 6+ years .
robertshaw wrote:
Thor6570 wrote: I believe shareholders should be demanding the company immediatley seek out JV's with Pharma. We are far to small and as result slow due to lack of $$$ and very extremley questionable Mgt financing decisions. They have shown this investor that they are unable to move fwd and conduct multiple trials concurrently. I mean WTF 5 + years and counting on bladder and we are not even at the quarter mark in phase 2. So another 10 years to go before we complete a second or third. The science indicates we have a cancer killer of many indications. How and why is this product not being expedited into the markey on multiple fronts. 
 
Perhaps the Covid 19 we be expedited somewhat by the University but by the time TLT mgt is ready to move fwd Covid 19 will have come and gone and we will have Covid 25 on our hands. My last point is after looking over the Company circular sent with voting proxy I note the salary's of the Mgt team and beieve that we are to heavy in this area for a company so small and not producing results. As well the BOD she be reduced in size. The funds saved should be diverted to immediatley starting a second indication. No excuses for holding up on second indication phase 1. The US Covid is out of control and in my opinion will be for some time. We may not see trial sites in the US until such time as they have covid control.

Enough of the slow moving snail paced action taken by this mgt. I do believe as someone posted earlier that with theses handsome salary's and options awarded and paid each year that these players have no incentive to speed things up. I mean over the past year what have they done to earn these salary;s ? Shut down for 4 months very few laser sales no communication nothing and yet how amny millions have we paid out in executive costs.

Enough is enough


Completely agree with you. Seek JV with potential partneners to speed up the trial process. We shareholders have the right to ask the management to do so.




Time for all the long suffered shareholders to unite to push the idiot style management to seek JV parteners right now. No excuse. As Sherry Mcfarland claimed on Aug. 23rd, 2017"... Bladder cancer, your days are numbered"... Now, the so called "numbered days" past over more than 1200 days, yet the idiot style managers of this promising technology make no movement, Enough is Enough.
Bullboard Posts